Download or read book CNS and Behavioural Pharmacology written by M. Airaksinen and published by Elsevier. This book was released on 2013-10-22 with total page 357 pages. Available in PDF, EPUB and Kindle. Book excerpt: CNS and Behavioural Pharmacology is the third volume of the proceedings of the Sixth International Congress of Pharmacology, organized by the Finnish Pharmacological Society and held in Helsinki, Finland, on July 20-25, 1975. Contributors focus on the findings concerning the central nervous system (CNS) and on the developments in behavioral pharmacology and related areas of research. This volume has 33 chapters divided into five sections. After discussing the application of psychopharmacology to the conservation of wild animals such as ungulates, this book turns its attention to alcohol dependence and the interactions between neurotransmitters and the hypothalamic releasing hormones. The reader is methodically introduced to the pharmacology of emotive behavior, with emphasis on drug effects in mental and emotional disorders as well as the action of psychotropic drugs on emotions, motivations, and social behavior of animals. The final section is devoted to the pharmacological aspects of the cerebrospinal fluid-transport system. This section covers topics such as the metabolism of biogenic amines in the human CNS; the importance of dopamine metabolism for the clinical effects and side effects of neuroleptics; and composite transport systems for organic acids and bases in choroid plexus. This book will be of interest to scientists representing all the major areas of pharmacology, including clinical pharmacology and toxicology, as well as to internists, psychiatrists, neurologists, and anesthesiologists.
Download or read book CNS and Behavioural Pharmacology written by International Congress of Pharmacology and published by . This book was released on 1975 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book CNS and Behavioural Pharmacology written by M. Airaksinen and published by Pergamon. This book was released on 1976 with total page 250 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book New Insights Into Behavioral Pharmacology written by Nuno Sousa and published by Frontiers Media SA. This book was released on 2021-11-12 with total page 133 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Neuropsychiatry and Behavioral Pharmacology written by C. Thomas Gualtieri and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 361 pages. Available in PDF, EPUB and Kindle. Book excerpt: Neuropsychiatry and Behavioral Pharmacology explores the neuropsychiatric consequences of congenital and acquired brain lesions and their appropriate pharmacologic treatment. The clinical problems addressed - practically, though always in a theoretical framework - are the severe behavioral disorders of children, of retarded people, of people with epilepsy, and of victims of traumatic brain injury. Topics examined include the neuropsychiatric and delayed neurobehavioral sequelae of traumatic brain injury, inadvertent drug effects, self-injurious behavior, Cornelia De Lange syndrome, autism, tardive dyskinesia, and childhood hyperactivity.
Download or read book Advances in Behavioral Pharmacology written by Travis Thompson and published by Psychology Press. This book was released on 2014-01-14 with total page 224 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume continues to document and summarize developments, trends, and emergent interdisciplinary research in behavioral psychopharmacology. For researchers and graduate students in psychopharmacology, behavioral pharmacology, toxicology, and the neurosciences. This seventh volume continues to document and summarize developments, trends, and emergent interdisciplinary research in behavioral psychopharmacology. For researchers and graduate students in psychopharmacology, behavioral pharmacology, toxicology, and the neurosciences. This is the latest volume in a series that continues to document and summarize developments, trends, and emergent interdisciplinary research in behavioral pharmacology, psychopharmacology, and the neurosciences. The chapters, written by authorities in their respective research areas, provide up-to-date examination and analysis of dominant evolving research areas. Designed as a resource text for professionals, as well as a supplementary text for upper level undergraduate and graduate students of behavioral pharmacology, psychopharmacology, psychobiology, and related fields, this book, like the others in the Advances in Behavioral Pharmacology Series, provides comprehensive coverage unavailable elsewhere.
Download or read book Behavioral Pharmacology of Neuropeptides Oxytocin written by Rene Hurlemann and published by Springer. This book was released on 2018-12-16 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of “precision medicine” approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.
Download or read book Behavioral Pharmacology written by Bernard Weiss and published by Springer Science & Business Media. This book was released on 2013-04-17 with total page 300 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Advances in Behavioral Pharmacology written by T. Thompson and published by Psychology Press. This book was released on 2014-04-04 with total page 336 pages. Available in PDF, EPUB and Kindle. Book excerpt: First published in 1987. Advances in Behavioral Pharmacology has broadened its scope in an attempt to provide a better understanding of behavioral actions of drugs and their applied implications. Each volume will be increasingly thematic and successive volumes will cover a wider range of issues. Some publications in this series, such as the present volume 6, Neurobehavioral Pharmacology, will primarily explore relations between neurochemistry and related areas of neurobiology and behavioral pharmacology.
Download or read book Animal and Translational Models for CNS Drug Discovery written by Robert A. McArthur and published by Academic Press. This book was released on 2008-11-27 with total page 1367 pages. Available in PDF, EPUB and Kindle. Book excerpt: Animal and Translational Models for CNS Drug Discovery combines the experience of academic, clinical and pharmaceutical neuroscientists in a unique collaborative approach to provide a greater understanding of the relevance of animal models of neuropsychiatric disorders and their role as translational tools for the discovery of CNS drugs being developed for the treatment of these disorders. The focus of this three-volume series of essays is to present a consensual picture of the translational value of animal models from leading experts actively involved in the use of animal models for understanding fundamental neurobiology of CNS disorders and the application of this knowledge to CNS drug discovery, and clinical investigators involved in clinical trials, drug development and eventual registration of novel pharmaceuticals. Each volume of the Animal and Translational Models for CNS Drug Discovery series is dedicated to the development and use of animal models in key therapeutic areas in psychiatric, neurologic and reward deficit disorders. Each volume has introductory chapters expressing the view of the role and relevance of animal models for CNS drug discovery and development from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in relevant therapeutic areas and discusses the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on Animal and Translational Models for CNS Drug Discovery is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. - Provides clinical, academic, government and industry perspectives fostering integrated communication between principle participants at all stages of the drug discovery process - Critical evaluation of animal and translational models improving transition from drug discovery and clinical development - Emphasizes what results mean to the overall drug discovery process - Explores issues in clinical trial design and conductance in each therapeutic area - Each volume is available for purchase individually.
Download or read book Behavioral Pharmacology of Drug Abuse Current Status written by and published by Academic Press. This book was released on 2022-03-25 with total page 458 pages. Available in PDF, EPUB and Kindle. Book excerpt: Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes of drugs of abuse, including nicotine, alcohol, opioids, psychostimulants, and hallucinogens, drug-environment interactions, neurochemical mechanisms and medications developments. This volume updates the field of behavioral pharmacology based on new knowledge gained in the past decade. Provides accurate and updated reviews from selected experts on covered topics Presents useful graphic material for ease of reading Covers a wide range of topics that are highly integral to offer a panoramic view of the field of behavioral pharmacology
Download or read book Drugs and Behavior written by Ernest L. Abel and published by John Wiley & Sons. This book was released on 1974 with total page 250 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Behavioral Pharmacology written by Susan D. Iversen and published by Oxford University Press, USA. This book was released on 1981 with total page 326 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Provides outstanding depth. .. For its size and price, it is perhaps the best and most readable integration of behavioral and physiological data on the effects of drugs." --Contemporary Psychology. "An excellent book. It deserves a wide readership and to become established as a standard basic text." --British Journal fo Clinical Psychology
Download or read book Animal and Translational Models for CNS Drug Discovery Neurological Disorders written by Robert A. McArthur and published by Academic Press. This book was released on 2008-11-18 with total page 416 pages. Available in PDF, EPUB and Kindle. Book excerpt: Neurological Disorders is written for researchers in both academia and the pharmaceutical industry who use animal models in research and development of drugs for neurological disorders such as neurofibromatosis, Alzheimer’s disease, Parkinson’s disease, Huntington disease, ALS, and the epilepsies. Neurological Disorders has introductory chapters expressing the view of the role and relevance of animal models for drug discovery and development for the treatment of psychiatric disorders from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in each therapeutic area covered and discuss the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on Animal and Translational Models for CNS Drug Discovery is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. This is the second volume in the three volume-set, Animal and Translational Models for CNS Drug Discovery 978-0-12-373861-5, which is also available for purchase individually. Clinical, academic, government and industry perspectives fostering integrated communication between principle participants at all stages of the drug discovery process Critical evaluation of animal and translational models improving transition from drug discovery and clinical development Emphasis on what results mean to the overall drug discovery process Exploration of issues in clinical trial design and conductance in each therapeutic area
Download or read book Methods of Behavior Analysis in Neuroscience written by Jerry J. Buccafusco and published by CRC Press. This book was released on 2000-08-29 with total page 341 pages. Available in PDF, EPUB and Kindle. Book excerpt: Using the most well-studied behavioral analyses of animal subjects to promote a better understanding of the effects of disease and the effects of new therapeutic treatments on human cognition, Methods of Behavior Analysis in Neuroscience provides a reference manual for molecular and cellular research scientists in both academia and the pharmaceutic
Download or read book CNS Receptors written by Paul Mandel and published by . This book was released on 1983 with total page 505 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Magnesium in the Central Nervous System written by Robert Vink and published by University of Adelaide Press. This book was released on 2011 with total page 354 pages. Available in PDF, EPUB and Kindle. Book excerpt: The brain is the most complex organ in our body. Indeed, it is perhaps the most complex structure we have ever encountered in nature. Both structurally and functionally, there are many peculiarities that differentiate the brain from all other organs. The brain is our connection to the world around us and by governing nervous system and higher function, any disturbance induces severe neurological and psychiatric disorders that can have a devastating effect on quality of life. Our understanding of the physiology and biochemistry of the brain has improved dramatically in the last two decades. In particular, the critical role of cations, including magnesium, has become evident, even if incompletely understood at a mechanistic level. The exact role and regulation of magnesium, in particular, remains elusive, largely because intracellular levels are so difficult to routinely quantify. Nonetheless, the importance of magnesium to normal central nervous system activity is self-evident given the complicated homeostatic mechanisms that maintain the concentration of this cation within strict limits essential for normal physiology and metabolism. There is also considerable accumulating evidence to suggest alterations to some brain functions in both normal and pathological conditions may be linked to alterations in local magnesium concentration. This book, containing chapters written by some of the foremost experts in the field of magnesium research, brings together the latest in experimental and clinical magnesium research as it relates to the central nervous system. It offers a complete and updated view of magnesiums involvement in central nervous system function and in so doing, brings together two main pillars of contemporary neuroscience research, namely providing an explanation for the molecular mechanisms involved in brain function, and emphasizing the connections between the molecular changes and behavior. It is the untiring efforts of those magnesium researchers who have dedicated their lives to unraveling the mysteries of magnesiums role in biological systems that has inspired the collation of this volume of work.
